<b>Background:</b> There is scanty guidance in the literature on the management of patients with glutamic acid decarboxylase (GAD65) antibody associated autoimmune epilepsy (GAD-epilepsy). This evidence concerns the gene GAD2 and generalized anxiety disorder.